Zhang, L., Jia, S., Ma, Y., Li, L., Li, X., Wang, X., . . . Zhang, M. (2016). Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: Interim analysis of a phase 4 study NCT01501149. Oncotarget.
Citación estilo ChicagoZhang, Lei, et al. "Efficacy and Safety of Cisplatin, Dexamethasone, Gemcitabine and Pegaspargase (DDGP) Regimen in Newly Diagnosed, Advanced-stage Extranodal Natural Killer/T-cell Lymphoma: Interim Analysis of a Phase 4 Study NCT01501149." Oncotarget 2016.
Cita MLAZhang, Lei, et al. "Efficacy and Safety of Cisplatin, Dexamethasone, Gemcitabine and Pegaspargase (DDGP) Regimen in Newly Diagnosed, Advanced-stage Extranodal Natural Killer/T-cell Lymphoma: Interim Analysis of a Phase 4 Study NCT01501149." Oncotarget 2016.